| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Pediatrics, Weill Medical College of Cornell University (B.I.C., R.S.N., S.N., M.I.N., R.C.W.), New York, New York 10021; Fondation Jean Dausset, Centre dÉtude du Polymorphisme Humain (L.P.), 75010 Paris, France; Baker Medical Research Institute (K.M.C.), 8008 Melbourne, Australia; and Childrens Hospital Los Angeles (T.F.R.), Los Angeles, California 90027
Address all correspondence and requests for reprints to: Maria I. New, M.D., Department of Pediatrics, Division of Pediatric Endocrinology, Weill Medical College of Cornell University, 525 East 68th Street, Room M-622, New York, New York 10021. E-mail: minew{at}mail.med
Congenital adrenal hyperplasia (CAH) consists of autosomal recessive
disorders of cortisol biosynthesis, which in the majority of cases
result from 21-hydroxylase deficiency. Another enzymatic defect causing
CAH is 11ß-hydroxylase deficiency. In both forms, the resulting
excessive androgen secretion causes genital virilization of the female
fetus. For over 10 yr female fetuses affected with 21-hydroxylase
deficiency have been safely and successfully prenatally treated with
dexamethasone. We report here the first successful prenatal treatment
with dexamethasone of an affected female with 11ß-hydroxylase
deficiency CAH. The family had two girls affected with
11ß-hydroxylase deficiency born with severe ambiguous genitalia who
were both homozygous for the T318M mutation in the
CYP11B1 gene, which codes for the 11ß-hydroxylase
enzyme. In the third pregnancy in this family, the female fetus was
treated in utero by administering dexamethasone to the
mother, starting at 5 weeks gestation. The treatment was successful, as
the newborn was not virilized and had normal female external genitalia.
A second family with two affected sons was also studied in preparation
for a future pregnancy. We report a novel 1-bp deletion in codon 394
(R394
1) in the CYP11B1 gene in this family.
This article has been cited by other articles:
![]() |
P. Glanc, S. Umranikar, D. Koff, G. Tomlinson, and D. Chitayat Fetal Sex Assignment by Sonographic Evaluation of the Pelvic Organs in the Second and Third Trimesters of Pregnancy J. Ultrasound Med., May 1, 2007; 26(5): 563 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Krone, F. G. Riepe, D. Gotze, E. Korsch, M. Rister, J. Commentz, C.-J. Partsch, J. Grotzinger, M. Peter, and W. G. Sippell Congenital Adrenal Hyperplasia Due to 11-Hydroxylase Deficiency: Functional Characterization of Two Novel Point Mutations and a Three-Base Pair Deletion in the CYP11B1 Gene J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3724 - 3730. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pinhas-Hamiel, Y. Zalel, E. Smith, R. Mazkereth, A. Aviram, S. Lipitz, and R. Achiron Prenatal Diagnosis of Sex Differentiation Disorders: The Role of Fetal Ultrasound J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4547 - 4553. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Collett-Solberg Congenital Adrenal Hyperplasia: From Genetics and Biochemistry to Clinical Practice, Part 2 Clinical Pediatrics, March 1, 2001; 40(3): 125 - 132. [Abstract] [PDF] |
||||
![]() |
P. C. White and P. W. Speiser Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Endocr. Rev., June 1, 2000; 21(3): 245 - 291. [Abstract] [Full Text] |
||||
![]() |
C G D Brook;, I. HUGHES;, and C. J H KELNAR Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2000; 82(3): 176F - 181. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |